×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
SESSION 1 : Regenerative Movements in New Drug Development to Provide Innovative Medicine to Patients in Asia and Worldwide
Session Chair(s)
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Masafumi Yokota, DVM, PhD
Senior Director
Daiichi Sankyo Co., Ltd., Japan
Speaker(s)
Singapore’s Regulatory Approach towards Clinical Genetics and Precision Medicine Services
Raymond S.B. Chua, MD, MBA, MPH, FRCP
Ministry of Health, Singapore
Deputy Director of Medical Services, Health Regulation Group
Digital Transformation in New Drug Development Worldwide: A US FDA Perspective
Theresa Mullin, PhD
FDA, United States
Associate Center Director - Strategic Initiatives, CDER
Digital Transformation of New Drug Development in JAPAN
Yasuhiro Fujiwara, MD, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Executive
Digital Transformation in New Drug Development NMPA Perspective and Practice
Shi Le
National Medical Products Administration, China
Department of Drug Registration
Korea’s Perspective on Innovative Medicine to Patients
Mee Ryung Ahn, PhD
Ministry of Food and Drug Safety, Korea, Republic of
Director